IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

SAFC: The Age of the Blockbuster Drug has ‘Disappeared’

10:31 PM MST | November 23, 2008 | Alex Scott

Sigma-Aldrich Fine Chemicals (SAFC), the fastest-growing division within the Sigma-Aldrich group, says it is adapting its business model to the “significantly” changing business environment. A fundamental change is the shift by big pharmaceutical companies away from blockbuster pharma products toward lower-volume, specialty drugs, says Frank Wicks, president of SAFC. Wicks: More flexibility is required. Pharma companies stand to lose $55 billion in sales during the next five years as a slew of drugs go off patent. “The specter of the blockbuster...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa